SCHEMBL5350784

SCHEMBL5350784

CC(C)(CO)C(O)c1cccc(C(O)C(C)(C)CO)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.37
PGK1 P00558 1/20 0.36
PGK2 P07205 1/20 0.36
AOC3 Q16853 1/20 0.36
VNN1 O95497 5/20 0.36
LMNA P02545 2/20 0.34
SLC6A3 Q01959 3/20 0.34
HIF1A Q16665 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRB3 P13945 1/20 0.34
TSHR P16473 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
NFKB1 P19838 1/20 0.34
DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703634 0.85 AOC3 (0.50) RIPK1AOC3LMNASLC6A3HIF1A
SCHEMBL1548351 0.80 AOC3 (0.46) RIPK1AOC3VNN1LMNASLC6A3
SCHEMBL4698142 0.80 UGT2B7 (0.55) AOC3VNN1SLC6A3HIF1ASLC6A2
SCHEMBL8837364 0.77 AOC3 (0.43) RIPK1AOC3VNN1LMNASLC6A3
SCHEMBL30149851 0.77 AOC3 (0.43) RIPK1AOC3VNN1LMNASLC6A3
Phosphoric Acid SCHEMBL8837421 0.77 AOC3 (0.43) RIPK1AOC3VNN1LMNASLC6A3
SCHEMBL7940010 0.76 AOC3 (0.42) RIPK1AOC3VNN1LMNASLC6A3
SCHEMBL12013626 0.76 PGK1 (0.40) RIPK1PGK1PGK2AOC3LMNA
SCHEMBL18548517 0.74 AOC3 (0.41) AOC3SLC6A2SLC6A4ADRB2ADRB1
SCHEMBL29493215 0.74 AOC3 (0.41) AOC3SLC6A2SLC6A4ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169446-B2 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-30 US disclosed
EP-1486526-B1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MED & GRAPHIC (JP) 2006-08-16 EP disclosed
US-20040252171-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2004-12-16 US disclosed
EP-1486526-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method Konica Minolta Medical & Graphic, Inc. (JP) 2004-12-15 EP disclosed